Perioperative anaesthetic practices in liver transplantation in France: Evolution between 2004 and 2008;Prise en charge anesthésique des transplantations h́patiques: Évolution des pratiques périopératoires en eFrance entre 2004 et 2008

Annales Francaises d'Anesthesie et de Reanimation

Volumn 29, Issue 6, 2010, Pages 419-424

  Paugam Burtz, C ^a   Chatelon, J ^a   Follin, A ^a   Rossel, N ^b   Chanques, G ^b   Jaber, S ^b  

^a BEAUJON HOSPITAL   (France)

^b HÔPITAL SAINT ELOI   (France)

Author keywords

Liver transplantation; Perioperative practices; Phone survey

Indexed keywords

CIPROFLOXACIN; ETOMIDATE; FLUCONAZOLE; MIDAZOLAM; PIPERACILLIN PLUS TAZOBACTAM; PROPOFOL; QUINOLINE DERIVED ANTIINFECTIVE AGENT; REMIFENTANIL; THIOPENTAL;

ANESTHESIOLOGICAL TECHNIQUES; ANESTHESIST; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE SEVERITY; FRANCE; GRAFT RECIPIENT; HEMODYNAMICS; HUMAN; LIVER TRANSPLANTATION; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; QUESTIONNAIRE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREND STUDY;

ADULT; ANESTHESIA; FRANCE; HUMANS; LIVER TRANSPLANTATION; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; TIME FACTORS;

EID: 77955051640     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2010.02.027     Document Type: Article

References (23)

1. Burroughs A.K., Sabin C.A., Rolles K., Delvart V., Karam V., Buckels J., et al. 3-month and 12-month mortality after first liver transplant in adults in Europe: Predictive models for outcome. Lancet 2006, 367:225-232.
2. Agence de biomédecine, Rapport d'activité 2008. Accès 02/10/2009 http://www.agence-biomedecine.fr/.
3. Rossel N., Jaber S., Sebbane M., Puche P., Chanques G., Perrigault P., et al. Enquête téléphonique sur les pratiques de l'anesthésie-réanimation de la transplantation hépatique en France. Ann Fr Anesth Reanim 2006, 25:R467. [résumé].
4. Agence de Biomédecine, Rapport d'activité 2007. Accès 23/09/2008 http://www.agence-biomedecine.fr/.
5. Wiesner R.H., McDiarmid S.V., Kamath P.S., Edwards E.B., Malinchoc M., Kremers W.K., et al. MELD and PELD: Application of survival models to liver allocation. Liver Transpl 2001, 7:567-580.
6. Lucey M.R., Mathurin P., Morgan T.R. Alcoholic hepatitis. N Engl J Med 2009, 360:2758-2769.
7. Tremelot L., Restoux A., Paugam-Burtz C., Dahmani S., Massias L., Peuch C., et al. Interest of BIS monitoring to guide propofol infusion during the anhepatic phase of orthotopic liver transplantation. Ann Fr Anesth Reanim 2008, 27:975-978.
8. Takizawa D., Sato E., Hiraoka H., Tomioka A., Yamamoto K., Horiuchi R., et al. Changes in apparent systemic clearance of propofol during transplantation of living related donor liver. Br J Anaesth 2005, 95:643-647.
9. Paugam-Burtz C., Kavafyan J., Merckx P., Dahmani S., Sommacale D., Ramsay M., et al. Postreperfusion syndrome during liver transplantation for cirrhosis: Outcome and predictors. Liver Transpl 2009, 15:522-529.
10. Walia A., Stoner T., Mandell S., Ayers D., Michaels D., Pandharipande P., et al. LTrAC 101-Looking for evidence [Abstract]. Liver Transpl 2008, 14:S212.
11. Walia A., Schumann R., Michaels D., Mercaldo N., Mandell S., Pandharipande P. LTrAC 201-Looking for evidence (2) [Abstract]. Liver Transpl 2009, 17:S87.
12. De Wolf A.M., Aggarwal S. Monitoring preload during liver transplantation. Liver Transpl 2008, 14:268-269.
13. De Wolf A.M. Pulmonary artery catheter: Rest in peace? Not just quite yet. Liver Transpl 2008, 14:917-918.
14. Ozier Y., Klinck J.R. Anesthetic management of hepatic transplantation. Curr Opin Anaesthesiol 2008, 21:391-400.
15. Biais M., Nouette-Gaulain K., Cottenceau V., Revel P., Sztark F. Uncalibrated pulse contour-derived stroke volume variation predicts fluid responsiveness in mechanically ventilated patients undergoing liver transplantation. Br J Anaesth 2008, 101:761-768.
16. Mukhtar A., Aboulfetouh F., Obayah G., Salah M., Emam M., Khater Y., et al. The safety of modern hydroxyethyl starch in living donor liver transplantation: A comparison with human albumin. Anesth Analg 2009, 109:924-930.
17. Ozier Y., Pessione F., Samain E., Courtois F. Institutional variability in transfusion practice for liver transplantation. Anesth Analg 2003, 97:671-679.
18. de Boer M.T., Christensen M.C., Asmussen M., van der Hilst C.S., Hendriks H.G., Slooff M.J., et al. The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg 2008, 106:32-44.
19. Pereboom I.T., de Boer M.T., Haagsma E.B., Hendriks H.G., Lisman T., Porte R.J. Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury. Anesth Analg 2009, 108:1083-1091.
20. Porte R.J., Molenaar I.Q., Begliomini B., Groenland T.H., Januszkiewicz A., Lindgren L., et al. Aprotinin and transfusion requirements in orthotopic liver transplantation: A multicentre randomised double-blind study. EMSALT Study Group. Lancet 2000, 355:1303-1309.
21. Molenaar I.Q., Warnaar N., Groen H., Tenvergert E.M., Slooff R.J. Efficacy and safety of antifibrinolytic drugs in liver transplantation: A systematic review and meta-analysis. Am J Transplant 2007, 7:185-194.
22. Bert F., Bellier C., Lassel L., Lefranc V., Durand F., Belghiti J., et al. Risk factors for Staphylococcus aureus infection in liver transplant recipients. Liver Transpl 2005, 11:1093-1099.
23. Jalan R., Williams R., Bernuau J. Paracetamol: Are therapeutic doses entirely safe?. Lancet 2006, 368:2195-2196.